Martindale Pharma improves Aurum pre-filled syringe packaging
To ensure ease of use and improve patient safety
The Aurum syringes are used for on-the-spot administration of drugs where high visibility and simple drug identification is crucial.
The Brentwood, Essex-based firm has redesigned the range to enhance ease of use and help improve patient safety. Specific improvements include new colour-differentiated packaging; colour-differentiated translucent boxes that confirm contents; and colour-differentiated labels. In addition the firm has improved tamper-evident labels and the packaging is latex-free and Luer Lock fitting.
The firm says its new colour-differentiated packaging meets national and international colour differentiation standards on syringe labelling and also the Royal College of Anaesthetists recommendations on syringe labelling in critical care.
You may also like
Packaging
Schreiner MediPharm to present novel RFID-Labels with digital seal function at CPHI 2024
Read moreSchreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, will be presenting a new RFID-Label with digital first-opening indication at CPHI in Milan
Trending Articles
Upcoming event
You may also like
Packaging
Schreiner MediPharm to present novel RFID-Labels with digital seal function at CPHI 2024
Schreiner MediPharm, a leading developer and manufacturer of innovative functional labels for the healthcare industry, will be presenting a new RFID-Label with digital first-opening indication at CPHI in Milan
Packaging
SCHOTT Pharma introduces blister-free syringe concept
As part of the Alliance to Zero goal to facilitate the pharmaceutical industry's transition to net-zero emissions, SCHOTT Pharma has teamed up with Schreiner MediPharm and Körber Pharma to develop a groundbreaking blister-free syringe concept
Regulatory
SGS’s Shanghai Health Science laboratory completes US FDA inspection with zero 483 observations
SGS, the world’s leading testing, inspection and certification company, has set a new benchmark for third-party pharmaceutical testing laboratories in China following an outstanding inspection by the US Food and Drug Administration (FDA) of its Shanghai Health Science Laboratory